|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-8-11
|
|
pubmed:abstractText |
A considerable fraction of prostate cancers harbor a gene fusion between the androgen-regulated TMPRSS2 and ERG, one of the most frequently over-expressed proto-oncogenes in prostate cancer. Here, we investigated if inherited genetic variation upstream of ERG alters prostate cancer risk and survival.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1573-7225
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1173-80
|
|
pubmed:meshHeading |
pubmed-meshheading:19205910-Aged,
pubmed-meshheading:19205910-Haplotypes,
pubmed-meshheading:19205910-Humans,
pubmed-meshheading:19205910-Male,
pubmed-meshheading:19205910-Middle Aged,
pubmed-meshheading:19205910-Polymorphism, Single Nucleotide,
pubmed-meshheading:19205910-Prostatic Neoplasms,
pubmed-meshheading:19205910-Proto-Oncogenes,
pubmed-meshheading:19205910-Risk Factors,
pubmed-meshheading:19205910-Serine Endopeptidases,
pubmed-meshheading:19205910-Survival Analysis,
pubmed-meshheading:19205910-Trans-Activators
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Genetic variation in the upstream region of ERG and prostate cancer.
|
|
pubmed:affiliation |
Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden. slindstr@hsph.harvard.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
